10x Genomics (TXG) Reports Q4 Loss, Tops Revenue Estimates

10x Genomics (TXG) came out with a quarterly loss of $0.40 per share versus the Zacks Consensus Estimate of a loss of$ 0.32. This compares to loss of $0.41 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -25%. A quarter ago, it was expected that this life science technology company would post a loss of$ 0.34 per share when it actually produced a loss of $0.30, delivering a surprise of 11.76%.Over the last four quarters, the co ...